Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.1 USD | +1.56% | +0.46% | -21.47% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.47% | 18.69B | |
+51.95% | 63.85B | |
-2.46% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.46% | 26.52B | |
+2.85% | 12.73B | |
+22.13% | 12.11B | |
+27.74% | 12.07B | |
-10.08% | 11.19B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Chardan Cuts Price Target on Alnylam Pharmaceuticals to $225 From $250, Expects Topline Results in Mid-2024, Maintains Buy Rating